Worth reading
47Recurring
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
84.3
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2023年4月1日〜2023年6月30日ConsolidatedJapanese GAAPNet Sales7,796¥ millionYear on year +13.3%Progress 26.7%
Operating profit315¥ millionYear on year +84.3%Progress 60.6%
Ordinary income1,119¥ millionYear on year +277.7%Progress 86.1%
Net income attributable to owners of the parent888¥ millionYear on year +296.1%Progress 99.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥32.55
Financial position at period-end
Total assets26,971¥ million
of which net assets 12,159 ¥ millionEquity ratio 45.1%vs. prior year-end +2.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueSugar business ¥7,294 million (YoY +14.0%), Bio Business ¥514 million (YoY +4.8%), Other ¥33 million (YoY +0.1%)
Segment profitSugar business ¥454 million (YoY +39.4%), Bio Business ¥114 million (YoY -16.6%), Other ¥18 million (YoY +14.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥29,200 million (YoY +4.5%)
Operating profit¥520 million (YoY -16.5%)
Ordinary income¥1,300 million (YoY +77.7%)
Net income¥890 million (YoY +78.6%)
Annual Dividend Forecast¥5 → ¥5（0.0%）
Factors Behind Changes in Business Performance
砂糖事業は原材料価格高騰の中で適正価格による販売に努めたことから売上高が増加。バイオ事業は原材料コスト等の上昇によりセグメント利益が減少。経常利益・純利益は出資先からの受取配当金の増加により増加。
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies (company name: —) / Excluded 0 companies (company name: —)
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End35,000,000 Shares
Treasury Shares at Period-End7,696,677 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2023年4月1日〜2023年6月30日 |
| Net Sales | ¥7,796 million (YoY +13.3%) |
| Operating profit | ¥315 million (YoY +84.3%) |
| Ordinary income | ¥1,119 million (YoY +277.7%) |
| Profit attributable to owners of the parent | ¥888 million (YoY +296.1%) |
| Net income per share | ¥32.55 |
| Equity ratio | End of the current fiscal period 45.1 / End of previous period 42.6 |
| Total assets | ¥26,971 million |
| Net assets | ¥12,159 million |
| Full-year earnings forecast | Net Sales ¥29,200 million (YoY +4.5%) / Operating profit ¥520 million (YoY -16.5%) / Ordinary income ¥1,300 million (YoY +77.7%) / Net income ¥890 million (YoY +78.6%) |
| Annual Dividend Forecast | ¥5 → ¥5（0.0%） |
| Segment revenue | Sugar business ¥7,294 million (YoY +14.0%), Bio Business ¥514 million (YoY +4.8%), Other ¥33 million (YoY +0.1%) |
| Segment profit | Sugar business ¥454 million (YoY +39.4%), Bio Business ¥114 million (YoY -16.6%), Other ¥18 million (YoY +14.8%) |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies (company name: —) / Excluded 0 companies (company name: —) |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 35,000,000 Shares |
| Treasury Shares at Period-End | 7,696,677 Shares |
| Factors Behind Changes in Business Performance | 砂糖事業は原材料価格高騰の中で適正価格による販売に努めたことから売上高が増加。バイオ事業は原材料コスト等の上昇によりセグメント利益が減少。経常利益・純利益は出資先からの受取配当金の増加により増加。 |
Items this document does not state (14)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogDepreciation and amortizationImpairment lossBreakdown of extraordinary income (loss)Material subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.砂糖事業では原材料価格高騰の中で適正価格による販売に努めたこと、バイオ事業では原材料コスト等が上昇したこと、経常利益と純利益では出資先からの受取配当金が増加したこと。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.